INTRODUCTION
Candida albicans is an opportunistic pathogen that causes oral, oesophageal and systemic infections in immunocompromised populations (Odds, 1988) . Over the past decade, Candida infections have increased dramatically with the rise in AIDS, cancer and bone marrow transplant patients (Georgopapadakou & Walsh, 1994) . The common use of azoles in the prophylaxis and treatment of candidiasis has led to the emergence of azole-resistant isolates. A recent study indicated that azole-resistant isolates were found in 20-30 % of HIV patients suffering from oral candidiasis (Perea et al., 2001) . Therefore, the discovery and development of new drug targets and compounds against fungal pathogens are greatly needed.
Approximately 0?5 % of mammalian cellular proteins are prenylated (Epstein et al., 1991) . Protein prenylation is an important and essential cellular process, which adds farnesyl diphosphate (FPP) and geranylgeranyl diphosphate (GGPP) derived from the ergosterol pathway to the C terminus of proteins (reviewed by Omer & Gibbs, 1994; Schafer & Rine, 1992; Sinensky & Lutz, 1992) . These isoprenoid groups anchor the proteins to the plasma membrane at the correct intracellular location. Prenylated proteins participate in a variety of cellular functions, such as the control of cell growth, differentiation, cytokinesis, membrane trafficking and signal transduction. Proteins that are prenylated include small GTP-binding proteins, lipopeptide pheromones, nuclear lamins and trimeric G-proteins (Schafer et al., 1989) . Many of these GTPases play crucial roles in cellsignalling pathways, which are likely to be involved in the pathogenesis of C. albicans.
To date, there are at least three prenyltransferases (PTFs) that have been identified in eukaryotic cells: farnesyltransferases (FTases), geranylgeranyltransferase I (GGTase I) and geranylgeranyltransferase II (GGTase II). All three PTFs are heterodimeric, magnesium-dependent zinc metalloenzymes, with the exception of mammalian GGTase I, which has been reported to require only zinc (Zhang & Casey, 1996) . PTFs catalyse prenyl group transfer from either FPP or GGPP onto the carboxyl terminus of proteins containing CAAX (C, cysteine; A, aliphatic amino acid; X, any amino acid), the recognition sequence for FTase and GGTase I, and CC and CAC, the recognition sequence for GGTase II (Casey & Seabra, 1996) . GGTase I and FTase in C. albicans have preferences for substrates that end in a leucine residue and methionine residue, respectively (Mazur et al., 1999) . GGTase II has not been characterized in C. albicans; however, the CC and CAC sequences have been demonstrated to be substrates for GGTase II in Saccharomyces cerevisiae (Farnsworth et al., 1994) .
All three PTFs in yeasts and mammals consist of a-and bsubunits. Previous studies on FTases have indicated that the b-subunit contains the binding sites for the FPP, peptide substrate and Zn 2+ , which is required for binding of the peptide substrate and enzyme activity (Reiss et al., 1991 (Reiss et al., , 1992 . The a-subunit of FTase contains the catalytic function and is required for stabilization of the b-subunit (Andres et al., 1993) . The a-subunit of both FTase and GGTase I is encoded by RAM2. The b-subunits of FTase and GGTase I are encoded by RAM1 and CDC43, respectively. The GGTase II a-and b-subunits are encoded by BET4 and BET2, respectively.
The ability to alter cell types between the yeast and hyphal form is an important virulence trait in C. albicans (Cutler, 1991; Odds, 1988 ). An important prenylated protein, Ras1p, has been found to be involved in serum-induced hyphal formation in C. albicans (Feng et al., 1999; Leberer et al., 2001) . Ras1p is one of the many prenylated proteins that have an important cellular role. A C. albicans strain that had both copies of ras1 deleted was viable, but its virulence was greatly reduced in the mouse model (Leberer et al., 2001) . Failure to prenylate Ras1p may lead to the inability of Candida to undergo the yeast-to-hyphal transition, as inhibition of prenylation blocks the membrane association and biological activity of both human and S. cerevisiae Ras proteins (Schafer et al., 1989) . Therefore, a disruption of RAM2 may result in disturbances of various cellular functions, including the yeast-to-hyphal transition.
Previous prenylation studies in fungi have focused on GGTase I, because its substrates, Rho1p and Cdc42p, are essential in important roles of morphogenesis in both S. cerevisiae and C. albicans (Drgonova et al., 1996; Kondoh et al., 1997; Mazur & Baginsky, 1996; Qadota et al., 1996) . In C. albicans, a gene deletion of CDC43 and the resulting absence of GGTase I activity did not affect the viability of the cells, while the same gene in S. cerevisiae could not be deleted, indicating that the gene is essential in S. cerevisiae (He et al., 1991; Kelly et al., 2000) . It was demonstrated that Candida FTase can add FPP onto GGTase I substrates and that this cross-farnesylation activity was greater in Candida than in Saccharomyces; thus, GGTase I activity is not essential in Candida (Caplin et al., 1994; Mazur et al., 1999) . GGTase II stands apart from the other PTFs both structurally and functionally (Casey & Seabra, 1996; Farnsworth et al., 1994) . Therefore, it would be unlikely that GGTase II would compensate for the loss of FTase and GGTase I activity (Kelly et al., 2000) . A disruption of the RAM2 gene would be expected to abolish both the GGTase I and the FTase activity. Since both activities would be affected, the RAM2 disruption would be expected to be detrimental to cell growth. Furthermore, the Candida Ram2p protein is only 30 % identical to human Ram2p, suggesting that it may be possible to identify fungal-specific inhibitors (Mazur et al., 1999) .
The heterozygote trisomy (HT) test was developed to identify essential genes in C. albicans, using PCR tests for homozygosis and triplication (Enloe et al., 2000) . In this study, the HT test results demonstrated that RAM2 is most likely essential for the viability of C. albicans. Minimum inhibitory concentration (MIC) drug-susceptibility tests and cell-free enzyme assays suggest that a PTF inhibitor is active against Candida FTase and GGTase I, but this drug may not access the C. albicans cytoplasm. In addition, an initial characterization of PTF subunits indicated that an overexpression of the a-subunit did not upregulate the b-subunits of FTase and GGTase I, suggesting that these genes may be regulated independently of each other.
METHODS
Cell growth and maintenance. The C. albicans strain BWP17 (ura3D : : limm434/ura3D : : limm434 his1 : : hisG/his1 : : hisG arg4 : : hisG/arg4 : : hisG) was generously provided by A. P. Mitchell (Wilson et al., 1999) . Cultures were routinely grown at 30˚C in YEPD medium (10 g yeast extract, 20 g peptone and 20 g glucose per litre) or on YEPD plates (YEPD and 10 g Bactoagar per 500 ml). Another lab strain, SS (Blagoyevich, 1979) , was also used in this study. The PCK1 promoter (see below) was induced in YEPC medium (10 g yeast extract, 20 g peptone and 20 g Casamino acids per litre). Transformants for the HT test were grown in synthetic defined media and plates, SD-Ura, SD-Arg and SD-Ura-Arg, prepared as described (Bio101). To induce hyphal formation, cells were grown in M199 at 37˚C for 3 h. Cells were subcultured routinely or stored at 280˚C in 10 % (v/v) glycerol. Cloning of RAM2 by inverted-PCR. Genomic DNA from strain SS (Blagoyevich, 1979) was digested with HindIII and electrophoresed in a 1 % low-melting-temperature gel in TAE buffer (40 mM Tris/HCl; 5?71 %, v/v, glacial acetic acid; 1 mM EDTA, pH 8?0). A 3 kb band, containing the RAM2 gene, was excised and purified using GeneClean (Bio 101) according to manufacturer's instructions. The DNA fragments were circularized by ligation at low concentrations in a reaction mix consisting of 10 mg gel-purified DNA, 100 ml of 106 ligase buffer and 5 ml T4 DNA ligase in a 1 ml volume. The ligation reaction was incubated at 15˚C overnight, then phenol/ chloroform extracted and ethanol precipitated at 280˚C for 1 h. The reaction mix was subsequently centrifuged, dried and resuspended.
Circularized DNA fragments were used as DNA template for PCR with oligonucleotide primers RAM2AR and RAM2CR, which were designed based on a partial 39 end of the RAM2 sequence available at that time (Scherer & Ran, 1996) (Table 1) . PCR products of approximately 1?5 to 3?5 kb in size were gel-purified, blunt-ended with Pfu DNA polymerases, ligated to PCR-Script Amp SK(+) cloning vectors and transformed into XL-1 Blue cells. Plasmids containing PCR inserts were isolated by using the Qiagen Plasmid Maxi Kit (Qiagen). Oligonucleotides were designed to sequence the 59 and 39 ends of the RAM2 gene in both orientations using an ABI automated DNA sequencer with Taq dye-primer and dye-terminator chemistries (Applied Biosystems). The RAM2 gene was sequenced together with 999 bp upstream and 180 bp downstream of the gene. The resulting sequence was deposited in GenBank under accession number AF548361.
Once the RAM2 sequence had been obtained, oligonucleotide primers RAMBamComp and RAMHindUra were used to amplify RAM2 from genomic DNA in a PCR. The PCR fragments were digested with restriction enzymes HindIII and BamHI, phenol/chloroform extracted and ethanol precipitated. The PCR fragments were cloned as described above. Plasmid pRAM1.65 contained the promoter, coding and terminator regions of RAM2, as determined by restriction enzyme analysis and DNA sequencing.
Southern and Northern blot analyses. Genomic DNA was digested with BamHI, BglII, HindIII, XbaI and EcoRV and Southern blot analysis was performed as described (Maniatis et al., 1982; Sambrook et al., 1989) . A 288 bp sequence of the RAM2 coding region was available in the Candida genome project. This was amplified by PCR and cloned into the PCR-Script Amp SK(+) vector, to generate pRAM-288. Plasmid pRAM-288 was labelled by random priming with [a-32 P]dATP and the large subunit of DNA polymerase I, and was used for Southern blot analysis (Klenow fragment) (Maniatis et al., 1982; Sambrook et al., 1989) .
For Northern blot analysis, overnight cultures were diluted to 4610 6 cells ml 21 and grown to 2610 7 to 3610 7 cells ml 21 (exponential growth). Total RNA was prepared and Northern blots were performed as described (Ausubel et al., 1995; Maniatis et al., 1982; Sambrook et al., 1989) . Probes used included CDC43-50, RAM1-50, ACT-50 and pRAM1.65 (Table 1) . mRNA signals were quantified using the Storm Phosphorimager and IMAGEQUANT software (Molecular Dynamics).
HT test. This was used to determine the essential function of RAM2 in C. albicans. PCR primers 59RAM80 and HT39RAM, containing 60 bp of the RAM2 promoter region and terminator region, respectively, and 20 bp of the polyclonal region of pBME101, were designed (Enloe et al., 2000; Wilson et al., 1999) (Table 1 ) (plasmid pBME101 contains the UAU1 cassette important for selections in the HT test). Standard PCRs included 16 PCR buffer, 0?2 mM each dNTP, 1 mM each primer and approximately 50 ng linearized pBME101. PCR conditions used were denaturing at 94˚C for 2 min followed by 30 cycles of denaturing at 94˚C for 1 min, annealing at 55˚C for 2 min and elongation at 72˚C for 3 min, with a final extension at 72˚C for 10 min.
Five micrograms of purified PCR products were added to a 40 ml aliquot of competent BWP17 cells as described previously (De Backer et al., 1999; Thompson et al., 1998) . The electroporation conditions used were 1?6 kV, 25 mF, 200 V with a Bio-Rad Gene Pulser. The cells were pelleted and resuspended in 500 ml of sterile double-distilled H 2 O (ddH 2 O) and plated onto SD-Arg plates with 250 ml of culture per Scherer & Ran (1996) , unpublished; C, Hoyer et al. (1994) , GenBank accession no. L25051; D, Losberger & Ernst (1989) , GenBank accession no. X16377. 4The RAM2 sequence is from contig 6-2394 and the RAM1 sequence is from contig 6-2230.
On: Tue, 18 Dec 2018 16:06:07 plate; they were then grown at 30˚C for 3-5 days. Transformed colonies were serially transferred three times to ensure a homogeneous transformant.
Heterozygotes (ram2 : : UAU1/RAM2) containing the UAU1 cassette from pBME101 were PCR-screened for a correct integration at the RAM2 locus with primers RAM2NA-D3, ARG 1282 and HT 1133 ( Table 1 ). The heterozygotes were plated out onto YEPD plates for 2 days at 30˚C. Lawns of cells were replica-plated onto SD-Arg-Ura plates and grown for 5-6 days at 30˚C. Transformants were screened by PCR with the same primers as described above.
Generation of inducible RAM2 strain B30. The inducible PCK1 promoter (Leuker et al., 1997 ; GenBank accession no. U70473) and a selectable marker, URA3, were integrated upstream of the RAM2 ATG start codon. A plasmid containing URA3 and the PCK1 promoter (pETE, constructed by Peter Silver) was linearized and used as the DNA template in PCRs. Oligonucleotides Ppck-crRAM, containing 60 bp of RAM2 coding sequence including the start codon and 20 bp of homology to the PCK1 promoter region, and PRam-PL, containing 60 bp of RAM2 promoter sequence and 20 bp of the polyclonal region upstream of URA3, were used as PCR primers (Table 1) . PCR products were phenol/chloroform extracted and ethanol precipitated. The PCR fragments were transformed into competent BWP17 as described above. Transformants with the inducible PCK1 promoter integrated upstream of the RAM2 ATG start codon were screened and verified by PCR, Southern blot analysis, DNA sequencing and Northern blot analysis.
RAM2 expression in yeast and hyphal growth states. After 48 h growth in YAD medium (1?7 g yeast nitrogen base, 5 g ammonium sulfate and 10 g glucose per litre), cells were washed twice in PBS (8 g NaCl, 0?2 g KCl, 1?44 g Na 2 HPO 4 and 0?24 g KH 2 PO 4 per litre) at pH 7?4. The culture was diluted to 2610 6 cells ml 21 and inoculated into either YAD at 25˚C at 180 r.p.m. or pre-warmed M199 medium at 37˚C at 300 r.p.m. (Bahn & Sundstrom, 2001) . Total RNA was extracted from yeast and hyphal cells after 4 h growth using TRIzol as described previously (Harry et al., 2002) . Total RNA was treated with RQ1 RNase-free DNase at 37˚C for 30 min, followed by phenol/chloroform extraction and ethanol precipitation. RT-PCR was performed using the Access RT-PCR System with 100-400 ng of RNA template according to the manufacturer's instructions. Oligonucleotide primers used for the RT-PCRs were RAM2NA-D3 and RAM2A to amplify RAM2, and ACT INTRN and ACTIN R to amplify ACT1 (Table 1) .
Antifungal-susceptibility testing. MIC values were determined according to the National Committee for Clinical Laboratory Standards (NCCLS) guidelines for antifungal-susceptibility testing (M27-A) (National Committee for Clinical Laboratory Standards, 1997). YAD supplemented with uridine, histidine and arginine was used as the test medium. MIC values were defined as an 80 % reduction in optical density compared with the growth control at 24 and 48 h.
Drugs used for the MIC tests included amphotericin B (stock concn 2?5 mg ml 21 in DMSO), FTase Inhibitor II (stock concn 10 mM in DMSO), GGTI-2147 (stock concn 10 mM in DMSO) and GGTI-286 (stock concn 10 mM in DMSO).
Preparation of cell extract. From an overnight culture grown in YEPD, cells were diluted to 8610 6 cell ml 21 in 1 l of medium and grown to between 2610 7 and 3610 7 cells ml 21 . Cells were centrifuged at 6000 g for 5 min at 4˚C. The cell pellet was washed twice with cold ddH 2 O and once with freshly prepared lysis buffer (20 mM Tris/HCl, pH 8?0; 5 mM ZnCl 2 ; 50 mM NaCl; 5 mM DTT). The wet weight of the cell pellet was determined and the pellet was resuspended in 0?56 the cell weight with lysis buffer supplemented with protease inhibitors: 1 mM PMSF (stock concn 100 mM in 2-propanol); 10 mg aprotinin ml 21 (stock concn 10 mg ml 21 in water); 10 mg leupeptin ml 21 (stock concn 10 mg ml 21 in water); 10 mg pepstatin A ml 21 (stock concn 5 mg ml 21 in methanol). Cells were transferred to a 50 ml conical tube and an equal volume of glass beads was added to the cell suspension. Cells were vortexed for 30 cycles of 10 s of beating with intervening 10 s of chilling on ice. The bottom of the 50 ml conical tube was pierced with a heated 18 gauge needle and the 50 ml conical tube was placed in 250 ml centrifuge tubes. The cell extracts were collected at 2000 g for 5 min at 4˚C, transferred to an ultracentrifuge tube and centrifuged at 100 000 g for 1 h at 4˚C. Cell extracts were aliquoted into 1?5 ml Eppendorf tubes and stored at 280˚C until use. The concentration of the cell extract was determined by using the Bradford assay (Bio-Rad) according to the manufacturer's instructions with BSA as the standard.
Cell-free enzyme assays. A 26 reaction buffer was made by adding solution 1 (60 mM KH 2 PO 4 ; 10 mM DTT; 1 mM MgCl 2 ; 40 mM ZnCl 2 ) to solution 2 (60 mM K 2 HPO 4 ; 10 mM DTT; 1 mM MgCl 2 ; 40 mM ZnCl 2 ) until pH 7?7 was reached. These solutions were aliquoted and stored at 280˚C. Exogenous enzyme substrates, Ras-CVLL (C, cysteine; V, valine; L, leucine) and Ras-WT (CVLS) (C, cysteine; V, valine; L, leucine; S, serine) were used in these assays. The enzyme reactions for the GGTase I were performed with 16 reaction buffer, 1 mM [ 3 H]GGPP, 10 mM Ras-CVLL, 20 mg cell extract and 0?02 % Triton X-100 in a total of 20 ml. The enzyme reactions for the FTase were performed with 16 reaction buffer, 1 mM [ 3 H]FPP, 10 mM Ras-WT, 20 mg cell extract and 0?02 % Triton X-100 in a total of 20 ml. All enzyme reactions were incubated at 30˚C for 90 min. Enzyme reactions were terminated with the addition of 56 sample buffer (300 mM Tris, pH 6?8; 200 mM DTT; 5 % SDS; 0?5 % bromophenol blue; 50 % glycerol) and heated for 3-5 min at 100˚C. Samples were briefly centrifuged and loaded on to 12 % SDS-PAGE gels, which were electrophoresed at 200 V for 45 min.
After electrophoresis, SDS-PAGE gels were soaked in 50 % methanol overnight to remove unbound [ 3 H]GGPP or [ 3 H]FPP, then washed three times for 15 min in glacial acetic acid. Gels were soaked in 20 % diphenyloxazole (PPO; Amersham Life Sciences) in glacial acetic acid (w/v) for 30 min and washed in water for more than 20 min until white precipitates were gone. The gels were dried at 60˚C for 1?5-2 h and exposed to Kodak BioMAX MS for 4 weeks at 280˚C.
RESULTS

Cloning of the single copy RAM2
A partial sequence of the RAM2 coding region became available early in the Candida genome-sequencing project. Based on this sequence, oligonucleotide primers were designed to amplify a 288 bp RAM2 DNA fragment using PCR. This partial RAM2 sequence was cloned into a plasmid (pRAM-288) and used as a radiolabelled probe for the Southern blot analysis. The Southern blot analysis identified a single hybridizing band in genomic DNA with five restriction enzymes (BamHI, BglII, HindIII, XbaI and EcoRV), demonstrating that there is one copy of the RAM2 gene per C. albicans genome (data not shown). The lack of additional bands at low stringency and long exposure demonstrated that additional, related genes were not present in the genome. This is confirmed by analysis of the currently available Candida genome sequence (Scherer & Ran, 1996) .
Inverted-PCR was used to clone and sequence the entire RAM2 gene from the laboratory strain SS, using a 3 kb HindIII fragment from genomic DNA (see Methods). Plasmid pRAM1.65 was constructed and contained 921 bp of the RAM2 coding region, 540 bp of the promoter region and 190 bp downstream of the stop codon from strain SS. This construct was later used as a radiolabelled probe for subsequent Southern blots to screen for correct transformants in gene deletion experiments.
Analysis of the RAM2 sequence
The RAM2 gene sequence from strain SS has several nucleotide and amino acid differences when compared to the RAM2 sequences from strain CA124 (Mazur et al., 1999) and strain SC5314 as determined by the Candida genomesequencing project (Scherer & Ran, 1996) (Table 2 ). In the coding region, there are 8 bp changes between SS and SC5314: two silent base pair differences at positions 92 and 723, and 6 bp changes that result in amino acid changes. There are 5 bp changes between SS and CA124, four of which result in amino acid changes. Of the 6 aa changes between all the strains, two are conservative (positions 38 and 242) and four are non-conservative (positions 41, 168, 176 and 244) ( Table 2 ). The SS and CA124 differences are a subset of the SS and SC5314 differences. In 999 bp of the promoter region upstream of the start codon ATG, there are 7 bp differences between SS and SC5314, 2 bp differences between SS and CA124, and 1 bp difference between SC5314 and CA124. All strains had identical nucleotide sequences 180 bp downstream of the stop codon.
RAM2 is expressed at low levels
To determine if RAM2 is expressed in yeast and hyphal cells, total RNA was extracted and analysed by Northern blot analysis and RT-PCR. By Northern blot analysis, RAM2 mRNA was undetectable in C. albicans and S. cerevisiae using the homologous gene fragment as a probe, while control ACT1 mRNA was easily detected (data not shown). RT-PCR did detect low levels of RAM2 mRNA in the yeast and hyphal forms of C. albicans (Fig. 1) . Total RNA was DNase-treated and amplified with the primers RAM2 and ACT1. The ACT1 PCR products indicate the extent of DNA contamination in RNA samples, since the PCR fragment spans the intron within the coding region of the actin transcript. The RT-PCR products amplified with the actin primers indicated that there was no detectable DNA contamination in the DNase-treated RNA samples. As the PCRs were not monitored during linear amplification of the product, it is not possible from this data to compare the levels of RAM2 mRNA transcript between yeast and hyphal samples.
RAM2 is essential
To determine the function of Ram2p, numerous attempts were made to disrupt both copies of the RAM2 gene. The 
Amino acid difference in the coding region341 C 38 NC 41 NC 168 NC 176 C 242 NC 244
*Nucleotide position relative to ATG, with A being +1. 3Highlighted areas represent identical nucleotides or amino acids between strains. 4Amino acid positions. 1C, conservative amino acid change; NC, non-conservative amino acid change. Fig. 1 . RT-PCR of RAM2 from yeast and hyphae. Total RNA was extracted from yeast and hyphae as described in Methods. RAM2NA-D3 and RAM2A were used to amplify RAM2, and ACT INTRN and ACTIN R were used to amplify ACT1 (Table 1 ). The ACT1 PCR products span the intron within the coding region of the actin transcript.
conventional URA-blaster strategy (Fonzi & Irwin, 1993) and PCR-based disruption cassettes that contain short regions of homology to the gene of interest (Wilson et al., 1999) were used to disrupt RAM2. Heterozygote strains (RAM2/ram2 : : URA3) were easily obtained with both gene disruption techniques. However, transformants that had undergone a second round of gene disruption at the RAM2 locus always retained a wild-type copy. Over 1000 transformants from the two methods were screened using PCR and Southern blot analysis to identify the double deletion of RAM2 without success (data not shown).
The HT test was developed by Mitchell and co-workers to create gene deletions and test putative essential genes in C. albicans (Enloe et al., 2000) . For this test, an UAU1 cassette containing an intact ARG4 gene flanked by URA3 deletion derivatives ura3D39 and ura3D59 was used. The URA3 deletion derivatives can recombine to yield an intact URA3 gene. Hence, ARG4 and URA3 were used as selectable markers in this test.
The UAU1 cassette flanked by DNA sequences homologous to RAM2 was transformed into BWP17 (arg4/arg4 ura3/ ura3 his1/his1). PCR primers were designed to screen the correct transformants (Fig. 2a) . The insertion of UAU1 at one allele of the RAM2 locus (ram2 : : UAU1/RAM2) was confirmed by PCR (Fig. 2b, lane 2) and Southern blot analysis (data not shown). These heterozygotes were able to survive in medium lacking arginine.
On rare occasions, under non-selective conditions, the UAU1 cassette can become homozygous through gene conversion or a mitotic recombination event at the gene of interest. Subsequent selection on medium lacking arginine and uridine identifies cells in which one copy of the UAU1 gene has undergone recombination to yield a functional URA3 gene and one copy of UAU1 remains intact. UAU1 and URA3 gene insertions in the two alleles of a nonessential gene would allow cells to grow on medium lacking both arginine and uridine. However, if the gene of interest was essential, cells that contain UAU1 and URA3 insertions in the two normal alleles will always retain an additional wild-type copy of the gene of interest from trisomy or translocation. Thirty independent heterozygotes of RAM2 (ram2 : : UAU1/RAM2) were grown in SD-Arg-Ura to select for URA + ARG + strains. When screened by PCR, all 30 independent URA + ARG + strains had three alleles of RAM2, including ram2 : : UAU1, ram2 : : URA3 and RAM2 (Fig. 2b) . Therefore, the HT test and the transformation data strongly suggest that RAM2 is an essential gene in C. albicans.
PTF inhibitors did not affect cell growth
An additional approach used to address the essential role of RAM2 is to inhibit FTase and GGTase I activities and to examine how this affects the cells. MIC studies were set up with several commercially available GGTase I and FTase inhibitors. Cells were treated with FTase Inhibitor II and two GGTase inhibitors (GGTI-286 and GGTI-2147), ranging from 0?1 nM to 100 mM. There was no change in cell growth in the presence of these inhibitors, even when 100 mM of the drugs were added to the culture (data not shown). Furthermore, when cells were treated with a Fig. 2. (a) Oligonucleotide primers for the HT test. PCR primers 1 (RAM2NA-D3) and 3 (HT1133) were within the RAM2 gene and outside of the UAU1 integration site; primer 2 (ARG 1282) was within the ARG4 gene within the UAU1 construct. Each PCR product size reflects the genotype of a possible transformant. (b) HT test of RAM2. Lane 1 contains the parental strain (RAM2/RAM2). This allele was detected with primers 1 and 3, generating a 1253 bp PCR fragment. Lane 2 contains the heterozygote strain (ram2 : : UAU1/RAM2). PCR from this strain detected the wild-type RAM2 allele (1253 bp fragment) and UAU1 allele (primers 2 and 3 generated a 2023 bp fragment). The PCR product with primers 1 and 3 was too large to be amplified when UAU1 was present. Lanes 3-6 contain four of the representative 30 independent strains that grew in the SDArg-Ura medium. PCR from these stains detected the ram2 : : URA3 allele (primers 1 and 3 generated a 2133 bp fragment) as well as RAM2 and the ram2 : : UAU1 allele.
combination of GGTI-2147 and FTase Inhibitor II in a checkerboard study, ranging from 0?1 nM to 100 mM, cell growth was not affected. Additional inhibitors, including a-hydroxyfarnesylphosphonic acid and FTase Inhibitor III in a similar range of drug concentrations, were also ineffective at inhibiting cell growth (data not shown).
Haploinsufficiency is a condition of diploid organisms in which a single copy of a gene is unable to maintain a wildtype phenotype, while two copies of the gene are necessary and sufficient for the wild-type phenotype (e.g. Giaever et al., 1999) . Heterozygote deletion strains of RAM2 (RAM2/ ram2 : : URA3) were tested with the PTF inhibitors. The heterozygote strains, like the wild-type strains, were unaffected by the drugs (data not shown).
The resistance of the fungal cells to PTF inhibitors may be due to efflux of the drug from the cell by efflux pumps such as CDR1, CDR2 and MDR1, pumps known to be involved in azole drug resistance in C. albicans (White et al., 1998) . A strain containing a deletion of all three pumps (CDR1, CDR2 and MDR1) was tested with the PTF inhibitors. The strain grew similar to wild-type strains (data not shown).
Enzyme assays indicated that FTase and GGTase I were inhibited in vitro
The lack of cell-growth inhibition by the PTF drugs may be due to the inability of the PTF drugs to inhibit Candida enzymes or to penetrate the cell wall and/or plasma membrane of C. albicans. The effect of PTF inhibitors on C. albicans FTase and GGTase I activities was therefore examined with cell-free enzyme assays. Cell extracts were incubated with [ 3 H]FPP and exogenous substrate Ras-WT to assay for FTase activity or [ FTase and GGTase I activities were observed in C. albicans cell extracts in the absence of drug (Fig. 3, lanes 2 and 5) and in the drug solvent DMSO (Fig. 3, lanes 3 and 6) . The prenylated exogenous substrates are indicated by the arrow in Fig. 3 ; the prenylated endogenous substrates are the upper and lower bands observed in some lanes. FTase Inhibitor II (50 mM) did not inhibit FTase enzyme activity (Fig. 3, lane 4) ; however, GGTI-2147 (50 mM) abolished GGTase I enzyme activity (Fig. 3, lane 7) . In the presence of both 50 mM FTase Inhibitor II and 50 mM GGTI-2147, the FTase and GGTase I enzyme activities were abolished (Fig. 3, lane 9) .
Regulation of the a-and b-subunits of FTase and GGTase I Since RAM2 encodes the common a-subunit of both the FTase and GGTase I, it was of interest to examine the regulation of these different subunits. To study how RAM2 overexpression might affect the regulation of the other two b-subunits at the transcriptional level, an inducible promoter from PCK1 was ligated upstream of the RAM2 ATG start codon. The PCK1 promoter is repressed by glucose (YEPD) and induced by gluconeogenetic carbon sources, such as Casamino acids (YEPC) (Leuker et al., 1997) .
PCR fragments containing URA3, 1435 bp of the PCK1 promoter region and flanking RAM2 sequences were transformed into BWP17 to generate strain B30, which contains the inducible PCK1 promoter ligated upstream of the RAM2 start codon. Strains BWP17 and B30 were grown in YEPD (repressing medium) and YEPC (inducing medium). Total RNA was prepared at the exponential growth phase. Northern blots were first hybridized with either the CDC43 probe or the RAM1 probe, followed by the RAM2 probe and then the ACT1 probe. The RAM2, RAM1 and CDC43 mRNA signals for each Northern blot were normalized to the ACT1 signal.
Northern blot analyses indicated that CDC43 and RAM1 were not upregulated when RAM2 was overexpressed. In repressing YEPD medium, there were no detectable levels of RAM2 in BWP17 and B30, but low levels of CDC43 and RAM1 were detectable (Fig. 4) . When B30 was grown in YEPC, the level of RAM2 RNA transcripts increased at least 11-to 13-fold above background, whereas both the CDC43 and RAM1 RNA transcript levels remained approximately the same. Therefore, an increase in RAM2 expression does not lead to an upregulation of RAM1 or CDC43 at the transcriptional level. 
DISCUSSION
In this study, the RAM2 gene, which encodes the common a-subunit of FTase and GGTase I, was examined in C. albicans. The results of the HT test strongly suggest that RAM2 is essential for the viability of C. albicans, similar to its orthologue in S. cerevisiae (He et al., 1991) . Low levels of RAM2 RNA transcripts were detected by RT-PCR in the yeast and hyphal growth states. The MIC studies of the PTF drugs against FTase and GGTase I showed that the drugs did not inhibit cell growth. However, cell-free enzyme assays indicated that at least one PTF drug inactivated FTase and GGTase I enzyme activities in C. albicans, suggesting that this drug may not be imported into the cells.
Previous sequence analysis of C. albicans CDC43 identified allelic and strain variations, including differences in the repetitive regions of the protein, deletions and amino acid changes among the three strains examined (Mazur et al., 1999) . Also, C. albicans Ram2p contained a D155G change in strains MY1055 and CA124 (Mazur et al., 1999) . Our sequence analysis of the Ram2p in strains SC5314, SS and CA124 indicated that there are more strain differences than previously described, suggesting that the coding sequence of RAM2 can also vary considerably (Table 2 ). This may have important implications for the development of drugs against Candida PTFs, since ideally the drugs would target the conserved regions of the PTFs.
In this study, it was hypothesized that a disruption of FTase and GGTase I activities would be detrimental to the Candida cells. Consistent with this hypothesis, deletion of both copies of RAM2 using the standard URA-blaster technique and the PCR-based short-homology technique were unsuccessful. Consistent with these observations, the results from the HT test showed that all 30 independent URA + ARG + mutants retained a wild-type copy of RAM2, indicating that RAM2 is most likely essential for the viability of C. albicans (Fig. 2b) . In Results, we also described the use of the inducible promoter PCK1. Inducible promoters can be used to study essential genes by turning expression of the gene off under repressing conditions. However, the PCK1 promoter does express under repressing conditions at levels that would be sufficient to complement a low-level expressed gene such as RAM2 (Ernst & Bockmuhl, 2002) .
It is a formal possibility that deletion of the RAM2 gene with the UAU1 cassette might disrupt the essential function of adjacent genes on the chromosome and that RAM2 might not be essential to C. albicans. While this possibility can not be eliminated by these results, several points can be made. First, the UAU1 cassette only replaced the coding region of RAM2, making it unlikely that it altered expression of adjacent genes. Second, the upstream adjacent gene IPF19970 has an unknown function but has some homology to a non-essential gene in S. cerevisiae. The downstream adjacent gene IPF14634 is an APP-1 binding protein (by homology), again a non-essential gene in S. cerevisiae. These two genes adjacent to RAM2 are encoded on the opposite strand, so the downstream gene is unlikely to be regulated by a change in RAM2. The gene upstream of IPF19970 is YTM1, which is an essential gene in S. cerevisiae. The gene downstream of IPF14634 is EFT3, which is a non-essential gene in S. cerevisiae. Therefore, adjacent genes are unlikely to explain the UAU1 result unless the construct is affecting the YTM1 gene function.
As RAM2 appears to be an essential gene, it is not surprising that RAM2 RNA transcripts were detected in the yeast and hyphal forms of C. albicans by RT-PCR (Fig. 1) . Since the Fig. 4 . CDC43 and RAM1 are not coupregulated with RAM2 transcriptionally. Strain BWP17 and the inducible strain B30 were grown in either inducing medium (I) or repressing medium (R) to mid-exponential phase at 30˚C and 180 r.p.m. as described in Methods. Two sets of Northern blots were prepared. The left panel was hybridized with CDC43-50, followed by pRAM1.65 and ACT-50. The right panel was hybridized with RAM1-50, followed by pRAM1.65 and ACT-50. Each mRNA signal was quantified using the Storm Phosphoimager and IMAGEQUANT software. The CDC43, RAM1 and RAM2 mRNA signals were normalized to ACT1 mRNA signals. The normalized mRNA levels in the inducing medium were divided by the normalized mRNA levels in the repressing medium, to compare the level of transcriptional induction. ND, Not detectable.
RT-PCR performed was not quantitative and continued for 35 cycles, the relative levels of RAM2 transcripts in yeast and hyphae growth states can not be compared in Fig. 1 .
The role of RAM2 is further examined by inhibiting both the FTase and GGTase I activities using pharmacological agents. Inhibition of both FTase and GGTase I activities would be expected to severely impair important cellular functions. PTF inhibitors of FTase and GGTase I had no effect on cell growth. Several possibilities exist: (i) the drugs may not penetrate the Candida cell membrane and/or cell wall; (ii) the drugs may be imported into the cells but do not inhibit Candida FTase and GGTase I; (iii) the drugs may be imported into the cells and may inhibit Candida FTase and GGTase I, but do not inhibit cell growth, as a result of drug modification, degradation, sequestration and/or efflux; (iv) the combined enzyme activities of FTase and GGTase I may not be essential to Candida. A heterozygote deletion was used to demonstrate that strains containing a single copy of RAM2 were similarly unaffected by the drugs.
In vitro enzyme assays were conducted with Candida cell extracts to determine if the drugs did inhibit PTF activity. The results demonstrated that FTase enzyme activity was not inhibited by 50 mM of FTase Inhibitor II, but GGTase I enzyme activity was inhibited by 50 mM of GGTI-2147. FTase and GGTase I enzyme activities were assayed together in the presence of both drugs at 50 mM. The two drugs together were able to inhibit FTase and GGTase I activities at the concentrations tested (Fig. 3, lane 9) . The most likely explanation is that 50 mM of GGTI-2147 is active against both enzymes, since FTase Inhibitor II is ineffective against Candida FTase at 50 mM. However, GGTI-2147 did not affect cell growth at 100 mM, in the presence or absence of FTase Inhibitor II. The IC 50 of GGTI-2147 for mammalian enzymes is 0?5 mM for GGTase I and >30 mM for FTase (Vasudevan et al., 1999) . Therefore, at 50 mM, GGTI-2147 may inhibit both Candida FTase and GGTase I in vitro, but does not affect cell growth. A subsequent experiment indicated that C. albicans FTase activity was significantly reduced in the presence of 100 mM of the FTase Inhibitor II (data not shown), indicating that a higher concentration of this drug alone is effective against C. albicans FTases. These results, together with the results from the HT test, indicated that the lack of inhibition on cell growth observed in the MIC studies might be due to the inability of GGTI-2147 to penetrate C. albicans. This suggested that the development of PTF inhibitors against Candida needs to focus on drug import. However, the possibility exists that GGTI-2147 might have been imported into the cell and is active against the enzyme, but is further modified, degraded, sequestered or effluxed from the cell. If efflux is involved, it is unlikely to be associated with the three efflux pumps associated with azole drug resistance (CDR1, CDR2 and MDR1), as a strain deleted of these three pumps was not altered in growth in the presence of these drugs. A more direct assay to measure prenylation activities in the living cells is needed to determine if the GGTI-2147 was imported into the cells and to determine its effect on PTF activities in vivo.
To gain a better understanding of the regulation of the aand b-subunits of FTase and GGTase I, the transcriptional regulation of the b-subunits was analysed in strain B30 containing the RAM2 gene, which encodes the a-subunit, fused to the inducible promoter. Surprisingly, little research has been done on the regulation of PTF subunits. Previous studies have demonstrated that overexpression of the Rab Escort Protein (REP), depletion of the GGPP pool and binding of the a-subunit to a protein tyrosine phosphatase may play a role in regulating GGTase II activity in S. cerevisiae (Miaczynska et al., 2001; Si et al., 2001) . The regulation of farnesylation has mostly been studied in mammalian cell systems, because of the intense interest in FTase inhibitors as chemotherapeutic agents. Insulin has been found to promote the activation of FTase and GGTase I, and the phosphorylation of the common a-subunit of these two enzymes via the Shc branch of intracellular signalling in CHO (Chinese hamster ovary) cells (Goalstone et al., 2001 ).
The results from the Northern blot analysis indicated that RAM2 is undetectable and that CDC43 and RAM1 are detectable, although not in abundant levels in a standard strain (Fig. 4) . Additionally, when RAM2 was overexpressed at least 11-to 13-fold in strain B30, which has one copy of RAM2 under the control of a regulable promoter, the RAM1 and CDC43 RNA levels were not upregulated, suggesting that these genes may be regulated independently of each other. Overexpression of RAM2 in strain B30 did not produce a difference in cellular morphology, growth rate or yeast-to-hyphal transition in repressing or inducing medium (data not shown).
This research has demonstrated that RAM2 is most likely an essential gene in C. albicans and has contributed to the fundamental understanding of protein prenylation, which is a crucial cellular process that may be explored as a new antifungal drug target in C. albicans.
